At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
HIV/AIDS
HIV/AIDS
-
-
Fighting the Syndemic: Addressing Opioid Use Disorder and Decreasing HIV Go Hand-in- Hand
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV. -
Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH. -
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady. -
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Latest News
Comparison of 3 Preventive Tuberculosis Therapies in Patients With HIV Infection
Researchers conducted a randomized trial that compared the effects of 3 treatment regimens for the prevention of tuberculosis infection among individuals with HIV infection currently taking antiretroviral therapy.
Effects of High-Dose vs Standard-Dose Hepatitis B Virus Revaccination Regimens in Patients With HIV infection
Investigators conducted a study that compared the efficacy of high- vs standard-dose hepatitis B virus revaccination regimens in patients with HIV infection.
Risk for Sudden Cardiac Death Up for People Living With HIV
Risk for sudden cardiac death increased among people living with HIV with elevated HIV viral load or low CD4 cell counts.
Combination Antiretroviral Therapy and CD4/CD8 Ratio on the Risk for Kaposi Sarcoma, Non-Hodgkin Lymphoma in Patients With HIV Infection
Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.
Association Between Drug Feedback and HIV Pre-Exposure Prophylaxis Adherence Among Young Women in Southern Africa
Researchers sought to assess whether retrospective drug feedback increased adherence to HIV pre-exposure prophylaxis among young women in South Africa and Zimbabwe.
Another HIV Vaccine Trial Canceled Due to Poor Results
Cancellation is the latest in a string of failures for HIV vaccine research.
Macular Structure and Microvasculature Degeneration in Patients With AIDS-Related Cytomegalovirus Retinitis
Researchers sought to assess the occurrence of macular and microvasculature structure degeneration among patients with active and inactive AIDS-related cytomegalovirus retinitis.
Prescribing Disparities for Integrase Strand Transfer Inhibitors in Patients With HIV Infection
In a secondary data analysis, investigators sought to assess potential prescribing disparities for integrase strand transfer inhibitors in patients with HIV infection.
Some High-Priority Groups More Likely to Stop Taking PrEP
Younger individuals, African American and Latinx, those with substance use disorders more likely to discontinue PrEP.
Effects of Dolutegravir vs Darunavir in Combination With Ziovudine or Tenofovir as Second-Line Treatment for HIV Infection
Researchers conducted a trial to compare the effects of dolutegravir vs darunavir in combination with either tenofovir or zidovudine as second-line treatment for patients with HIV infection.
Among Persons With HIV, More Finish Short-Course TB Prophylaxis
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy.
Outcomes of COVID-19 in Patients With and Without HIV infection
Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.
Does HIV Status Affect Neurosyphilis or Ocular Syphilis Outcomes?
Researchers conducted a study to compare the clinical characteristics and outcomes of early symptomatic neurosyphilis and ocular syphilis in patients with or without HIV infection.
Specific Gene Silencing Induces Apoptosis of HIV-Infected Macrophages
Investigators performed a genome-wide screening study to determine whether silencing specific genes induces apoptosis of HIV-infected macrophages.
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) for preventing HIV infection.
The Role of Equity in HIV Pre-Exposure Prophylaxis Programs in High-Income Countries
The outcomes of this review will provide relevant information for healthcare professionals, policy makers, and commissioners about how best to evaluate national PrEP programs.
Clopidogrel Preferred to Reduce Heart Disease Risk in Patients With HIV
Researchers sought to determine whether clopidogrel would be preferred over aspirin to reduce cardiovascular risk in patients with HIV.
Prevalence of Transmitted Drug Resistance to Tenofovir, Emtricitabine in Newly Diagnosed HIV Infection
Investigators conducted a retrospective molecular epidemiologic study to assess transmitted drug resistance in patients recently diagnosed with HIV infection.
Cytomegalovirus Seropositivity May Affect Epigenetic Aging in Healthy Older Adults
Investigators conducted a study to determine whether cytomegalovirus affects epigenetic age and immune dysregulation in healthy older adults who are asymptomatic.
Emtricitabine and Tenofovir Alafenamide Safe, Effective for Long-Term HIV-1 Pre-Exposure Prophylaxis
In a randomized controlled trial, researchers compared emtricitabine and tenofovir alafenamide with tenofovir disoproxil fumarate for reducing the risk of HIV infection in high-risk cisgender men and transgender women who have sex with men.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...